
Preliminary data from a phase 3 trial has met its trigger point in total COVID-19 infections, and the interim findings look good for mRNA-1273.

Preliminary data from a phase 3 trial has met its trigger point in total COVID-19 infections, and the interim findings look good for mRNA-1273.

A discrepancy regarding a pre-licensing inspection of a third-party manufacturing facility led to the Complete Response Letter.

A new IRIS registry analysis reports that many patients with geographic atrophy do not continue follow-up after initial visit or consultation.

RD surgery and scleral buckle appear to be preferred among ophthalmologists—but are linked to further necessary care in children.

Retinal nerve fiber layer density also appears to be influenced by presentation of both conditions.

Geeta Lalchandani-Lalwani, MD discusses the importance of early DR detection as well as findings from her study that suggest a need for more personalized therapies.

A new trial shows treatment-naive patients with nAMD have similar BCVA and safety outcomes with the biosimilar.

For patients with ETDRS DRSS scores of 47-53, about 40% experienced 2-step DR worsening by year 5.

Data show patients can decrease annual injections while retaining, if not improving, on BCVA scores over 104 weeks.

Lynn Hassman, MD, talks about a promising new technology that can optimize precision medicine in patients with uveitis.

New findings suggest the common ophthalmic disorder in premature infants could be three-fold more prevalent in multiracial infants.

In data presented at AAO, investigators examine the impact of anti-VEGF injections on ocular hypertension.

New AAO 2020 findings suggest even geographical differences could define retinal detachment risks among nearsighted patients.

In data presented at AAO, investigators find BI 836680 shows early signals of bioactivity.

In data presented at AAO 2020, researchers discover new methods for detecting different underlying conditions.

The study presented at AAO provides an update on previously shared 6-month data from earlier this year.

Raymond Douglas, MD, PhD, discusses data that demonstrate the benefit of teprotumumab in patients with all levels of thyroid eye disease.

The study authors noted that dementia prevention could become a compelling indication for older individuals receiving antihypertensive treatment.

The estimated the prevalence of C diff infections is about 40 in 30,000 for the sickle cell disease group and about 5000 in 11.8 million for the non-sickle cell disease group.

Mortality linked to household air pollution has dropped by more than one-third in the past 2 decades, but the greatest improvements have come in countries where such pollution is not a major problem.

There was a substantial increase in drug use-related endogenous endophthalmitis hospitalizations between 2003 and 2016.

SimpleSENSE is a first-of-its-kind cloth-based diagnostic platform that can capture more than 100 million data points per patient per day across cardiac, pulmonary, and circulatory biomarkers.

Identifying early stages of chronic kidney disease in patients with sickle cell anemia has the potential of allowing for personalized treatment and better prognosis.

A new study confirms the link between chronic urticaria and fibromyalgia, though the correlation is not as strong as in a previous study.

The incidence or urticaria in patients does not depend on exposure to air pollution.

Longer studies are needed to determine the effectiveness and durability of CDI interventions.

Nightware provides vibrations when it senses the user is having a nightmare.

Supernus indicates no efficacy or safety concerns from their pediatric ADHD medication.

A greater number of cumulative days of montelukast use did not increase the risk of ADHD in these patients.

A new health care pathway could be safe to implement in clinical practice.